David Turkaly
Stock Analyst at Citizens
(2.17)
# 2,808
Out of 5,172 analysts
148
Total ratings
38.06%
Success rate
-3.8%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Maintains: Market Outperform | $78 → $85 | $76.43 | +11.21% | 11 | Feb 27, 2026 | |
| AXGN Axogen | Maintains: Market Outperform | $34 → $42 | $30.78 | +36.45% | 9 | Feb 24, 2026 | |
| MDXG MiMedx Group | Initiates: Market Outperform | $10 | $4.12 | +142.72% | 1 | Feb 23, 2026 | |
| SYK Stryker | Upgrades: Market Outperform | $440 | $335.67 | +31.08% | 4 | Dec 19, 2025 | |
| TELA TELA Bio | Maintains: Market Outperform | $7 → $5 | $0.78 | +542.59% | 7 | Nov 14, 2025 | |
| APYX Apyx Medical | Upgrades: Market Outperform | $8 | $3.48 | +129.89% | 6 | Nov 12, 2025 | |
| KIDS OrthoPediatrics | Maintains: Market Outperform | $35 → $25 | $16.52 | +51.33% | 12 | Oct 10, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $11.65 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $86.26 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $58.58 | +70.71% | 12 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $265 → $280 | $220.03 | +27.26% | 18 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $35 → $25 | $8.94 | +179.64% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $62 → $55 | $21.85 | +151.72% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $140 → $125 | $87.87 | +42.26% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $400 → $500 | $408.99 | +22.25% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $105.41 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $12.79 | +150.20% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $4.48 | +257.14% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $1.45 | +106.90% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $7.95 | -37.11% | 1 | Oct 6, 2017 |
Lantheus Holdings
Feb 27, 2026
Maintains: Market Outperform
Price Target: $78 → $85
Current: $76.43
Upside: +11.21%
Axogen
Feb 24, 2026
Maintains: Market Outperform
Price Target: $34 → $42
Current: $30.78
Upside: +36.45%
MiMedx Group
Feb 23, 2026
Initiates: Market Outperform
Price Target: $10
Current: $4.12
Upside: +142.72%
Stryker
Dec 19, 2025
Upgrades: Market Outperform
Price Target: $440
Current: $335.67
Upside: +31.08%
TELA Bio
Nov 14, 2025
Maintains: Market Outperform
Price Target: $7 → $5
Current: $0.78
Upside: +542.59%
Apyx Medical
Nov 12, 2025
Upgrades: Market Outperform
Price Target: $8
Current: $3.48
Upside: +129.89%
OrthoPediatrics
Oct 10, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $16.52
Upside: +51.33%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $11.65
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $86.26
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $58.58
Upside: +70.71%
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $220.03
Upside: +27.26%
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $8.94
Upside: +179.64%
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $21.85
Upside: +151.72%
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $87.87
Upside: +42.26%
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $408.99
Upside: +22.25%
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $105.41
Upside: -
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $12.79
Upside: +150.20%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $4.48
Upside: +257.14%
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $1.45
Upside: +106.90%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $7.95
Upside: -37.11%